Angels Rotate Rotation as Rodriguez's Back Sidelines Him Mid-Season

Grayson Rodriguez exited his Sunday start against Tampa Bay after 2⅓ innings with low-back tightness, landing on the 15-day injured list before Monday's game against Arizona. The move caps a frustrating stretch for the 26-year-old right-hander, who opened the season on the same shelf with right shoulder inflammation and hadn't pitched in the majors since July 31, 2024, following a lat strain and elbow surgery. Back-to-back injury interventions in a single year suggest a body that hasn't yet stabilized under Major League workload.

Rodriguez had been threading a needle this season: through six starts, he posted a 24-to-15 strikeout-to-walk ratio across 25⅔ innings—a respectable K/BB shape that indicated improving command despite a bloated 8.06 ERA. The back tightness, which he reported feeling on a specific pitch in the third inning, isn't necessarily catastrophic. Manager Kurt Suzuki framed it as precautionary, a way to prevent aggravation rather than to address structural damage. Rodriguez himself said he'd been managing back discomfort in recent starts before it flared. This distinction matters: the Angels appear to be managing a chronic mechanical or postural issue rather than a sudden tear or disc problem. Still, the timing is brutal—the moment a pitcher's command begins clicking, injury intervenes.

The roster response reveals both organizational optimism and uncertainty. The Angels called up José Fermin from Triple-A to bolster the bullpen and purchased Brett Kerry's contract as insurance depth. Kerry, a 27-year-old journeyman making his Major League debut after 581⅓ minor-league innings, gives them a live arm with some leverage innings experience. The rotation slot itself remains unfilled. Caden Dana, who took a Triple-A start on Sunday and allowed seven runs in 3⅔ innings, is one path. George Klassen, their No. 4 prospect, who walked four over three scoreless innings in his own Triple-A outing on Saturday, is another. The Angels are deferring the decision—a smart hedge when the injury timeline is genuinely unclear.

For bettors, the uncertainty tilts the board in predictable directions. Angels team totals and run-line props tighten when rotation depth becomes a question, particularly mid-game adjustments where quality-start odds compress. Rodriguez was posting a 5.31 ERA at home in Anaheim; whoever fills that slot will likely operate with less command and higher leverage. Over the next 15 days, lean unders on Angels team totals against above-average offenses—the combination of bullpen fatigue (more relief innings due to shortened starter outings) and reduced rotation quality creates a drag on run production. Fermin's 5.40 ERA in 15 Major League innings is not an upgrade over what Rodriguez was delivering; it's a replacement player scenario masquerading as a move.

Pomeranz's departure via designate-for-assignment at 37 with a 5.01 ERA is the inevitable endgame for a $4 million one-year contract signed by an organization that needed bullpen depth in March. By June, the math no longer works. The real telling detail is that Fermin, despite his own 5.40 ERA in the majors, is the organization's preferred option—a vote of no-confidence in Pomeranz's ability to navigate a season. The Angels are cycling bodies faster than they're solving depth problems.